FI20011403A - Menetelmä ja koostumukset vatsan sairauksien hoitoon - Google Patents

Menetelmä ja koostumukset vatsan sairauksien hoitoon Download PDF

Info

Publication number
FI20011403A
FI20011403A FI20011403A FI20011403A FI20011403A FI 20011403 A FI20011403 A FI 20011403A FI 20011403 A FI20011403 A FI 20011403A FI 20011403 A FI20011403 A FI 20011403A FI 20011403 A FI20011403 A FI 20011403A
Authority
FI
Finland
Prior art keywords
procedures
compositions
treatment
gastric diseases
gastric
Prior art date
Application number
FI20011403A
Other languages
English (en)
Swedish (sv)
Inventor
Jari Natunen
Halina Miller-Podraza
Susann Teneberg
Jonas Aangstroem
Karl-Anders Karlsson
Original Assignee
Carbion Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Carbion Oy filed Critical Carbion Oy
Priority to FI20011403A priority Critical patent/FI20011403A/fi
Priority to US10/482,046 priority patent/US20040180850A1/en
Priority to US10/482,045 priority patent/US20040176320A1/en
Priority to EP02751212A priority patent/EP1411952B1/en
Priority to PCT/FI2002/000574 priority patent/WO2003002127A1/en
Priority to AT02751212T priority patent/ATE429233T1/de
Priority to EP02751213A priority patent/EP1411953A1/en
Priority to JP2003508367A priority patent/JP2004537538A/ja
Priority to AU2002352531A priority patent/AU2002352531A1/en
Priority to PCT/FI2002/000575 priority patent/WO2003002128A1/en
Priority to DE60232077T priority patent/DE60232077D1/de
Priority to AU2002352533A priority patent/AU2002352533A1/en
Priority to JP2003508366A priority patent/JP2005504017A/ja
Publication of FI20011403A publication Critical patent/FI20011403A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/739—Lipopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
FI20011403A 2001-06-29 2001-06-29 Menetelmä ja koostumukset vatsan sairauksien hoitoon FI20011403A (fi)

Priority Applications (13)

Application Number Priority Date Filing Date Title
FI20011403A FI20011403A (fi) 2001-06-29 2001-06-29 Menetelmä ja koostumukset vatsan sairauksien hoitoon
US10/482,046 US20040180850A1 (en) 2001-06-29 2002-06-28 Methods and compositions for treatment of gastric diseases
US10/482,045 US20040176320A1 (en) 2001-06-29 2002-06-28 Use of at least one glycoinhibitor substance
EP02751212A EP1411952B1 (en) 2001-06-29 2002-06-28 Use of at least one glycoinhibitor substance against infectious diseases
PCT/FI2002/000574 WO2003002127A1 (en) 2001-06-29 2002-06-28 Use of at least one glycoinhibitor substance
AT02751212T ATE429233T1 (de) 2001-06-29 2002-06-28 Verwendung mindestens einer glycoinhibitor- substanz gegen infektionskrankheiten
EP02751213A EP1411953A1 (en) 2001-06-29 2002-06-28 Methods and compositions for treatment of gastric diseases
JP2003508367A JP2004537538A (ja) 2001-06-29 2002-06-28 胃疾患を治療するための方法および組成物
AU2002352531A AU2002352531A1 (en) 2001-06-29 2002-06-28 Use of at least one glycoinhibitor substance
PCT/FI2002/000575 WO2003002128A1 (en) 2001-06-29 2002-06-28 Methods and compositions for treatment of gastric diseases
DE60232077T DE60232077D1 (de) 2001-06-29 2002-06-28 Verwendung mindestens einer glycoinhibitor-substanz gegen infektionskrankheiten
AU2002352533A AU2002352533A1 (en) 2001-06-29 2002-06-28 Methods and compositions for treatment of gastric diseases
JP2003508366A JP2005504017A (ja) 2001-06-29 2002-06-28 少なくとも１種の糖含有阻害性物質の用途

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20011403A FI20011403A (fi) 2001-06-29 2001-06-29 Menetelmä ja koostumukset vatsan sairauksien hoitoon

Publications (1)

Publication Number Publication Date
FI20011403A true FI20011403A (fi) 2002-12-30

Family

ID=8561536

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20011403A FI20011403A (fi) 2001-06-29 2001-06-29 Menetelmä ja koostumukset vatsan sairauksien hoitoon

Country Status (6)

Country Link
US (1) US20040180850A1 (fi)
EP (1) EP1411953A1 (fi)
JP (1) JP2004537538A (fi)
AU (1) AU2002352533A1 (fi)
FI (1) FI20011403A (fi)
WO (1) WO2003002128A1 (fi)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1476454A1 (en) * 2002-01-18 2004-11-17 Biotie Therapies Corp. Binding epitopes for helicobacter pylori and use thereof
FI20021989A0 (fi) * 2002-11-06 2002-11-06 Halina Miller-Podraza Korkean affiniteetin Helicobacter pylori-reseptorit ja niiden käyttö
WO2004065400A1 (en) * 2003-01-20 2004-08-05 Glykos Finland Oy Novel binding epitopes for helicobacter pylori and use thereof
US20060210688A1 (en) * 2005-03-18 2006-09-21 Mower Thomas E Dehydrated sports drink powder
US20060210697A1 (en) * 2005-03-18 2006-09-21 Mower Thomas E Infant formula composition
US20070020358A1 (en) * 2005-03-18 2007-01-25 Mower Thomas E Sports drink concentrate
US20060210692A1 (en) * 2005-03-18 2006-09-21 Mower Thomas E Baby food composition
US7776365B2 (en) * 2005-03-18 2010-08-17 Sakura Properties, Llc Article with skin protecting and moisturizing compound
US7749545B2 (en) 2005-03-18 2010-07-06 Sakura Properties, Llc Fucoidan compositions and methods for dietary and nutritional supplements
US20060210496A1 (en) * 2005-03-18 2006-09-21 Mower Thomas E Compositions for skin protection from ultraviolet damage
US7666448B2 (en) 2005-03-18 2010-02-23 Sakura Properties, Llc Skin cleansing article
JP5035787B2 (ja) * 2005-10-04 2012-09-26 焼津水産化学工業株式会社 α−１、４結合型Ｎ−アセチルグルコサミン含有Ｏ−グリカン型糖鎖の分泌促進剤並びにこれを含有するヘリコバクターピロリ菌を原因とする病態の治療予防剤
US8512761B2 (en) * 2006-01-27 2013-08-20 Yale University Fast acting inhibitor of gastric acid secretion
CA2635272C (en) * 2006-01-27 2016-11-29 Yale University Fast acting inhibitor of gastric acid secretion
JP5140246B2 (ja) * 2006-03-15 2013-02-06 公益財団法人野口研究所 Ｎ−アセチルグルコサミンの誘導体を含有するピロリ菌増殖抑制剤
WO2008032817A1 (fr) * 2006-09-14 2008-03-20 Riken Chaîne de sucre ayant une activité à l'encontre de l'helicobacter pylori
JP5014018B2 (ja) * 2006-10-18 2012-08-29 旭化成ケミカルズ株式会社 ピロリ菌の抑制剤または静菌剤
JP5501969B2 (ja) * 2007-09-11 2014-05-28 ユニバーシティ オブ グェルフ クロストリジウム・ディフィシル由来の多糖免疫原
JP5465542B2 (ja) * 2008-02-22 2014-04-09 片山化学工業株式会社 合成糖脂質含有リポソーム
RU2410100C2 (ru) * 2009-03-30 2011-01-27 Александр Владимирович Диковский Фармацевтическая композиция ингибитора протонной помпы и пребиотика для лечения язвенных поражений желудка и 12-перстной кишки
WO2011079349A1 (en) * 2009-12-31 2011-07-07 Okada Medical Services Pty Ltd Okadaella gastrococcus and cancer
RU2665948C1 (ru) * 2017-08-22 2018-09-05 Анастасия Владимировна Серебрянская Лекарственный препарат для наружного применения
CN113274404A (zh) * 2020-06-28 2021-08-20 天翊生物医药科技(天津)有限公司 医用吸附树脂的新用途及幽门螺杆菌消除药物
CN112842997B (zh) * 2021-04-08 2022-08-12 青岛海洋生物医药研究院股份有限公司 一种同时抑制幽门螺旋杆菌和具核梭杆菌的口服海洋多糖纳米胶束及其制备方法和应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK17885D0 (da) * 1985-01-14 1985-01-14 Karlsson Karl Anders Antiviralt middel
JPH0220292A (ja) * 1988-07-06 1990-01-23 Agency Of Ind Science & Technol 低分子化キトサンの製造方法
US5217715A (en) * 1988-08-01 1993-06-08 The United States Of America As Represented By The Department Of Health And Human Services Carbohydrate receptor for bacteria and method for use thereof
US5204118A (en) 1989-11-02 1993-04-20 Mcneil-Ppc, Inc. Pharmaceutical compositions and methods for treating the symptoms of overindulgence
ATE232730T1 (de) * 1991-08-23 2003-03-15 Alberta Res Council Verfahren und zusammensetzungen zur verhinderung der antikörper-vermittelten abstossung von xenogenen transplantaten
MX9304638A (es) * 1992-07-31 1994-05-31 Neose Pharm Inc Composicion para tratar e inhibir las ulceras gastricas y duodenales.
DE69225979T2 (de) * 1992-08-13 1998-12-17 Teikoku Seiyaku Co. Ltd., Kagawa Orale zubereitung zur freisetzung im unteren verdauungstract
US5679375A (en) * 1995-06-07 1997-10-21 C.V. Therapeuctics Method of treating ulcers with sulfated polysaccharides
EP0918526A1 (en) * 1996-05-03 1999-06-02 Neose Technologies, Inc. Bismuth salt of sialyloligosaccharide and a method for treating and inhibiting gastric and duodenal ulcers with same
HU225329B1 (en) 1996-09-12 2006-09-28 Richter Gedeon Vegyeszet Use of zinc or cobalt hyaluronate associate for the manufacture of pharmaceutical compositions of antimicrobial activity
WO1999064469A1 (fr) * 1998-06-09 1999-12-16 Ghen Corporation INHIBITEURS DE FIXATION DE $i(HELICOBACTER PYLORI)
CN1309666B (zh) * 1998-07-21 2011-07-27 阿尔平斯托克控股有限公司 葡糖醛酸葡聚糖的聚合物复合物
WO2000020009A1 (fr) 1998-10-05 2000-04-13 Kabushiki Kaisha Yakult Honsha Agents antibacteriens et leur procede de preparation
KR100324441B1 (ko) * 1999-02-08 2002-02-27 이은선 위염, 위궤양, 십이지장궤양 예방을 위한 식품
SE9901007D0 (sv) * 1999-03-19 1999-03-19 Thomas Boren Use of fucosylated sialylated N-acetyl lactosamin carbohydrate structures for inhibition of bacterial adherence
SE9904581D0 (sv) * 1999-12-15 1999-12-15 A & Science Invest Ab A novel helicobacter pylori-binding substance and use thereof
US6492350B2 (en) * 2000-01-27 2002-12-10 Jdc (Hawaii) Inc. Chitin oligosaccharides and/or chitosan oligosaccharides for preventing or treating common cold or treating pain
WO2002047612A2 (en) * 2000-10-27 2002-06-20 Mannatech, Inc. Dietary supplement compositions

Also Published As

Publication number Publication date
US20040180850A1 (en) 2004-09-16
EP1411953A1 (en) 2004-04-28
WO2003002128A1 (en) 2003-01-09
JP2004537538A (ja) 2004-12-16
AU2002352533A1 (en) 2003-03-03

Similar Documents

Publication Publication Date Title
FI20011403A (fi) Menetelmä ja koostumukset vatsan sairauksien hoitoon
CY2019030I1 (el) Παραγωγο ραπαμυκινης για την θεραπευτικη αντιμετωπιση του καρκινου του πνευμονα
NO20033594L (no) Fenetanolamin-derivater for behandling av luftveissykdommer
DE60239648D1 (de) Pharmazeutische Zusammensetzungen zur Behandlung von Asthma
CY2014019I2 (el) Παραγωγα φαιναιθανολαμινης για θεραπεια ασθενειων του αναπνευστικου
NO20053077D0 (no) Terapeutiske formuleringer for behandling av beta-amyloid-relaterte sykdommer.
ATE384522T1 (de) Medikamente zur chemotherapeutischen behandlung von erkrankungen
ATE414512T1 (de) Kombinationstherapie zur behandlung von krebs
DE50013843D1 (de) Arzneimittel zur behandlung von darmerkrankungen
DE60236743D1 (de) Zur behandlung androgenabhängiger krankheiten
DE60218375D1 (de) Pharmazeutische Zusammensetzung zur Behandlung gynäkologischer Erkrankungen
NO20034123L (no) Fremgangsmåte for behandling av brennstoff
NO20054346D0 (no) Sammensetninger og fremgangsmater for forebygging og behandling av endotoksinrelaterte sykdommer og tilstander
NO20020784D0 (no) Medikament for behandling av brudd
FI20011947A0 (fi) Menetelmä suorittimen toiminnan ohjaamiseksi ja suoritin
NO20033341D0 (no) Metoder for administrering av epothilone-analoger for behandling av kreft
EP1472273A4 (en) COMPOSITIONS AND METHODS FOR TREATING IMMUNE DISEASES
NO20020369L (no) Sammensetninger for forebyggelse og behandling av nyredysfunksjoner og -sykdommer
FI990781A0 (fi) Menetelmä lentotuhkan käsittelemiseksi
NO20012612L (no) Isonipecotamider for behandlingen av integrin-formidlede sykdommer
NO20043113L (no) Fremgangsmate for behandling av benforstyrrelse
ATE443060T1 (de) Benzoägüchinolinderivate zur behandlung von glaucom und kurzsichtigkeit
FI20011034A0 (fi) Menetelmä absorboivien aineiden valmistamiseksi
DE60114448D1 (de) Imidazolonderivate zur behandlung viraler krankheiten
FI20010892A0 (fi) Menetelmä ksylitolin valmistamiseksi